Pacira Pharmaceuticals, Inc. Stock Performance
as on November 21, 2025 at 2:29 am IST
Day's High
$22.79$24.959.48%
Upside
52 Week's Low
52 Week's High
$16.29$27.64
28.52%
Downside
21.28%
Upside
Pacira Pharmaceuticals, Inc. share price movements today
- Previous Close
- $24.33
- Open
- $24.33
- Volume
- 509.3K
- Day's Low - High
- $22.79 - $24.95
- 52 Week Low - High
- $16.29 - $27.64
Pacira Pharmaceuticals, Inc. Historical Returns
- 1 Month Return
- + 5.69 %
- 3 Month Return
- -2.64 %
- 1 Year Return
- + 42.87 %
- 3 Year Return
- -50.39 %
- 5 Year Return
- -63.28 %
Pacira Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Check Pacira Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.1B
EPS (TTM)
2.9667
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.48%
PE Ratio (TTM)
51.89
Industry PE ratio
-0.8126129032258065
PEG Ratio
-3.83
EBITDA
150.6M
Revenue (TTM)
716.8M
Profit Margin
2.99%
Return On Equity TTM
2.90%
Pacira Pharmaceuticals, Inc. Stock Valuation
Track how Pacira Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Pacira Pharmaceuticals, Inc. in the last 5 years
Lowest (5.36x)
September 30, 2024
Industry (-0.81x)
November 20, 2025
Today (51.89x)
November 20, 2025
Highest (32.47x)
March 31, 2021
Today’s Price to Earnings Ratio: 51.89x
Pacira Pharmaceuticals, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Pacira Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.1B | -63.28% | 51.89 | 2.99% | |
| BUY | $21.6B | NA | 18.05 | 40.65% | |
| BUY | $43.0B | NA | 21.84 | 13.81% | |
| BUY | $13.8B | 55.12% | 33.09 | 15.95% | |
| BUY | $52.4B | -29.55% | 19.89 | 28.21% |
Stock Returns calculator for Pacira Pharmaceuticals, Inc. Stock including INR - Dollar returns
The Pacira Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pacira Pharmaceuticals, Inc. investment value today
Current value as on today
₹1,38,993
Returns
₹38,993
(+38.99%)
Returns from Pacira Pharmaceuticals, Inc. Stock
₹33,823 (+33.82%)
Dollar Returns*
₹5,171 (+5.17%)
Analyst Recommendation on Pacira Pharmaceuticals, Inc. Stock
Based on 16 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Pacira Pharmaceuticals, Inc.. Average target price of $30.17
Pacira Pharmaceuticals, Inc. Share Price Target
Get share price movements and forecasts by analysts on Pacira Pharmaceuticals, Inc..
What analysts predicted
24.46%UPSIDE
Target Price
$30.17
Current Price
$22.79
Analyzed by
16 Analysts
Target
$30.17
Pacira Pharmaceuticals, Inc. target price $30.17, a slight upside of 24.46% compared to current price of $22.79. According to 16 analysts rating.
Pacira Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest
Search interest for Pacira Pharmaceuticals, Inc. Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:13% versus previous 30 day period
Pacira Pharmaceuticals, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Pacira Pharmaceuticals, Inc. Annual Profit & Loss
All numbers in Millions USD
Pacira Pharmaceuticals, Inc. Quarterly Cash Flow
All numbers in Millions USD
Pacira Pharmaceuticals, Inc. Annual Cash Flow
All numbers in Millions USD
Pacira Pharmaceuticals, Inc. News & Key Events
Today's Timeline - 21 October
Tue, 06:05 PM
-Pacira Biosciences received a PIV Notice from WhiteOak regarding a generic version of EXPAREL, asserting patent invalidity.
Insights on Pacira Pharmaceuticals, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, -4.84M → 5.43M (in $), with an average increase of 189.2% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, PCRX stock has moved up by 3.0%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PCRX has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 3 years, United Therapeutics Corporation has given 80.1% return, outperforming this stock by 130.5%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 181.09M → 179.51M (in $), with an average decrease of 0.9% per quarter
About Pacira Pharmaceuticals, Inc.
| Organisation | Pacira Pharmaceuticals, Inc. |
| Headquarters | 5401 West Kennedy Boulevard, Tampa, FL, United States, 33609 |
| Industry | Health Technology |
| CEO | Mr. Frank D. Lee |
| E-voting on shares | Click here to vote |
Key Management of Pacira Pharmaceuticals, Inc.
Name | Title |
|---|---|
Mr. Anthony Molloy III, Esq. | Chief Legal & Compliance Officer |
Ms. Krys Corbett Esq. | Chief Business Officer |
Mr. Frank D. Lee | CEO & Director |
Mr. Shawn M. Cross | Chief Financial Officer |
Ms. Lauren Bullaro Riker | Principal Accounting Officer & Senior VP of Finance |
Ms. Kristen Williams Esq., J.D. | Chief Administrative Officer & Secretary |
Dr. Jonathan Slonin M.D. | Chief Medical Officer |
Ms. Susan Mesco | Head of Investor Relations |
Mr. Christopher C. Young | Chief Manufacturing Officer |
Mr. Brendan P. Teehan | Chief Commercial Officer |
FAQs
What is Pacira Pharmaceuticals, Inc. share price today?
Pacira Pharmaceuticals, Inc. share price today is $22.79 as on at the close of the market. Pacira Pharmaceuticals, Inc. share today touched a day high of $24.95 and a low of $22.79.
What is the 52 week high and 52 week low for Pacira Pharmaceuticals, Inc. share?
Pacira Pharmaceuticals, Inc. share touched a 52 week high of $27.64 on and a 52 week low of $16.29 on . Pacira Pharmaceuticals, Inc. stock price today i.e. is closed at $22.79,which is 17.55% down from its 52 week high and 39.90% up from its 52 week low.
What is Pacira Pharmaceuticals, Inc.'s market capitalisation today?
Pacira Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
How to invest in Pacira Pharmaceuticals, Inc. Stock (PCRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Pacira Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pacira Pharmaceuticals, Inc. Shares that will get you 0.0658 shares as per Pacira Pharmaceuticals, Inc. share price of $22.79 per share as on November 21, 2025 at 2:29 am IST.
What is the minimum amount required to buy Pacira Pharmaceuticals, Inc. Stock (PCRX) from India?
Indian investors can start investing in Pacira Pharmaceuticals, Inc. (PCRX) shares with as little as ₹88.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.80 in Pacira Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pacira Pharmaceuticals, Inc. share’s latest price of $22.79 as on November 21, 2025 at 2:29 am IST, you will get 0.4388 shares of Pacira Pharmaceuticals, Inc.. Learn more about
fractional shares .
What are the returns that Pacira Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?
Pacira Pharmaceuticals, Inc. stock has given -63.28% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?